This is a phase 1 study to assess the routes of elimination of a single oral dose of [14C]
PF-00868554 and to characterize the metabolic profile following single dose administration.
- Male, healthy volunteers.
Questions about a trial? Call or email to reach a Pfizer Clinical Trial Contact Center Representative
Pfizer Clinical Trials Contact Center
call now email
Contact a representative by phone, email, or visiting the study website. Please see the references below: